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Abstract
Background: Primary autosomal recessive microcephaly (MCPH) is a rare neurodevelopmental disorder that results
in severe microcephaly at birth with pronounced reduction in brain volume, particularly of the neocortex, simplified
cortical gyration and intellectual disability. Homozygous mutations in the Cyclin-dependent kinase 5 regulatory
subunit-associated protein 2 gene CDK5RAP2 are the cause of MCPH3. Despite considerable interest in MCPH as a
model disorder for brain development, the underlying pathomechanism has not been definitively established and
only four pedigrees with three CDK5RAP2 mutations have been reported. Specifically for MCPH3, no detailed
radiological or histological descriptions exist.
Methods/Results: We sought to characterize the clinical and radiological features and pathological cellular
processes that contribute to the human MCPH3 phenotype. Haplotype analysis using microsatellite markers around
the MCPH1-7 and PNKP loci in an Italian family with two sons with primary microcephaly, revealed possible linkage
to the MCPH3 locus. Sequencing of the coding exons and exon/intron splice junctions of the CDK5RAP2 gene
identified homozygosity for the novel nonsense mutation, c.4441C > T (p.Arg1481*), in both affected sons. cMRI
showed microcephaly, simplified gyral pattern and hypogenesis of the corpus callosum. The cellular phenotype was
assessed in EBV-transformed lymphocyte cell lines established from the two affected sons and compared with
healthy male controls. CDK5RAP2 protein levels were below detection level in immortalized lymphocytes from the
patients. Moreover, mitotic spindle defects and disrupted γ-tubulin localization to the centrosome were apparent.
Conclusion: These results suggest that spindle defects and a disruption of centrosome integrity play an important
role in the development of microcephaly in MCPH3.
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Introduction
Primary autosomal recessive microcephaly (MCPH) delin-
eates a genetically heterogeneous and rare subgroup of con-
genital microcephalies characterized by a pronounced
reduction of brain volume, particularly of the neocortex,
simplified gyral pattern and intellectual disability [1,2].
Homozygous mutations of the Cyclin-dependent kinase 5
regulatory subunit-associated protein 2 gene, CDK5RAP2
(OMIM*608201), were identified in 2005 as a cause for
MCPH type 3 (MCPH3, OMIM#604804) [3]. To date,
three different mutations have been identified: two in three
Pakistani families and one mutation in a Somali patient:
(i) a nonsense mutation in exon 4 (c.246T >A, p.Y82X),
(ii) an A to G transition in intron 26 (c.4005-15A >G, p.
R1334SfsX5) introducing a new splice acceptor site, a frame
shift and a premature stop codon, and (iii) a nonsense
mutation in exon 8 (c.700G >T, p.E234X) [3-5]. All three
mutations have been proposed, but not shown, to lead to a
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CDK5RAP2 is associated with the centrosome, micro-
tubuli and Golgi apparatus, is enriched in neural progeni-
tors within the ventricular and subventricular zone of the
immature brain, can be also detected in glial cells and
early neurons, and is strongly downregulated with brain
maturation [6,7]. One current model for the microcephaly
phenotype caused by CDK5RAP2 mutation invokes a
premature shift from symmetric to asymmetric neural pro-
genitor cell divisions with a subsequent depletion of the
progenitor pool and a reduction in the final number of neu-
rons, and decreased cell survival [6,8]. Underlying mecha-
nisms include a deregulation of the role of CDK5RAP2
in centrosome function, spindle assembly and/or response
to DNA damage [6,8]. Despite considerable interest in
MCPH as a neural stem cell defect and window into
the control of neurogenesis in humans, the underlying
pathomechanisms have not been definitively established
and specifically for MCPH3, no detailed radiological de-
scriptions of patients or functional analyses in patient
samples have been reported to date.
In the present study, we report a novel CDK5RAP2muta-
tion and describe for the first time in detail the clinical,
radiological and cellular phenotype in two MCPH3 patients
of European descent. We are thereby able to attribute the
microcephaly phenotype in MCPH3 at least partially to a
mitotic spindle defect and centrosome disorganization.
Material and methods
Patients
Informed consent was obtained from the parents of the
patients for the molecular genetic analysis, the publication
of clinical data, magnetic resonance images (MRI) and
studies on immortalized lymphocytes (LCLs). DNA was
extracted from EDTA blood samples using the Illustra
BACC2 DNA extraction kit (GE Healthcare, Munich,
Germany). Samples from microcephaly patients and con-
trols were used in this study with approval from the local
ethics committees of the Charité and the Freiburg Univer-
sity (approval nos. EA1/212/08 and 494/11, respectively).
Haplotype analysis using microsatellite markers
Six microsatellite markers were selected for each of the
MCPH1 to 7 and PNKP loci, so that three markers were
located on each side of each gene. The markers flanking
the CDK5RAP2 gene were: CHLC.GGAA23B10, D9S258,
D9S2152, D9S103, D9S116 and D9S1823. PCR was
performed with 1 ng patient DNA and primer pairs in
which the forward primer was always labeled with 6-FAM.
PCR fragments were resolved by capillary electrophoresis
on an ABI 3100 sequencer. Fragment analysis was per-
formed using GeneScan software (Applied Biosystems,
Foster City). Haplotypes were constructed in the family by
inspection of the microsatellite fragment lengths.
PCR and DNA sequencing
Thirty-eight coding exons of the CDK5RPAP2 gene and at
least 50 bp of the intronic, exon-flanking sequence were
analyzed by PCR (Taq Polymerase, Qiagen, Hilden,
Germany), and cycle sequencing using the ABI Prism
BigDye Terminator Cycle Sequencing Ready Reaction Kit
Version 1.1 (Applied Biosystems, Darmstadt, Germany).
Capillary electrophoresis was performed using an ABI 3100
sequencer (Applied Biosystems, Foster City, CA, USA). Se-
quence data were analyzed using SeqPilot DNA sequence
analysis software (JSI, Kippenheim, Germany). The data-
base sequence NM_018249 for the CDK5RAP2 gene was
used as reference, and primers were developed in our la-
boratory (available on request).
Establishment of Ebstein-Barr virus-transformed
lymphocytes and culture
Ebstein-Barr virus-transformed lymphocytes (LCLs) were
established according to the protocol published by
Neitzel et al. 1986 [9]. Non-adherent LCLs were cultured
in RPMI 1640 with L-Glutamine (Invitrogen, Darmstadt,
Germany) supplemented with 20% v/v fetal bovine serum
(Invitrogen) and 1% v/v penicillin-streptomycin (Sigma-
Aldrich, Taufkirchen, Germany).
Immunocytology
For fixation, cells were plated on Poly-L-lysine (Sigma-Al-
drich) coated coverslips, cultured for 30 min in standard
conditions, and incubated in 37°C PFA 4% for 10 min
prior to rinsing with phosphate buffered saline (PBS 1×).
Coverslips were further incubated at room temperature
(RT) in staining buffer (0,2% gelatin, 0,25% Triton X-100
in PBS 1×) for 20 min and subsequently in 10% donkey
normal serum (DNS) in staining buffer for 30 min for
blocking. Coverslips were incubated overnight at 4°C with
primary antibodies in the staining buffer containing 10%
DNS followed by an incubation with the corresponding
secondary antibodies for 2 h at RT. Nuclei were labeled
with 4’,6-diamidino-2-phenylindole (DAPI, 1:1000, Sigma-
Aldrich). Fluorescently labeled cells were analyzed and
imaged by a fluorescent Olympus BX51 microscope with
the software Magnafire 2.1B (2001) (Olympus, Hamburg,
Germany), and all images were processed using Adobe
Photoshop. The anti-CDK5RAP2 antibody (HPA035820;
1:200) utilized in this study recognizes amino acids
1307–1390 of CDK5RAP2 which is unique for the
human CDK5RAP2 protein sequence (accession no.
NP_060719.4, Uniprot Q96SN8). Further primary an-
tibodies were as follows: mouse anti-γ-tubulin (T5326,
Sigma-Aldrich, 1:5000), mouse anti-alpha-tubulin (T9026,
Sigma-Aldrich; 1:1500), mouse anti-pericentrin (ab28144,
Abcam; 1:1000), mouse anti-acetylated alpha-tubulin
(T6793, Sigma-Aldrich; 1:1000), mouse anti-GM130
(610823, BD Biosciences; 1:1000).
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Protein extraction procedure and Western blot
Protein extracts for Western blots were isolated from LCLs
by homogenization in radio-immunoprecipitation assay
(RIPA) buffer containing 1 mM phenylmethylsulfonyl
fluoride (PMSF; Sigma-Aldrich) and 1 protease inhibitor
cocktail tablet per 10 ml RIPA buffer (Complete Mini;
Roche Diagnostics, Mannheim, Germany), 20 min incuba-
tion on ice and centrifugation at 4°C for 10 min at 3000 g
and for 20 min at 16000 g. Protein concentrations were de-
termined using a bicinchoninic acid (BCA) based assay,
according to the instructions of the manufacturer (BCA
Protein Assay Kit; Pierce Biotechnology, Rockford, IL,
USA). Protein extracts (30 μg per sample) were dena-
turated in Laemmli sample loading buffer at 95°C for
5 min, separated by sodium dodecyl sulphate polyacryl-
amide gel electrophoresis (SDS-PAGE) and electrophoret-
ically transferred in transfer buffer in a semi-dry fashion
using Trans-Blot SD Semi-Dry transfer cell (Bio-Rad,
Munich, Germany) onto nitrocellulose membrane (Bio-
Rad, Munich, Germany). The membranes were incubated
for 1 h at RT in blocking buffer (TBS-T 1x with 5% bovine
serum albumin (BSA)), rinsed three times with TBS-T
(1x) for 8 min each at RT on a shaker and then incubated
overnight at 4°C with rabbit anti-CDK5RAP2 (1:200,
HPA035820, Sigma-Aldrich; also verified with antibody
from Abnova PAB17507, 1:200), mouse anti-γ-tubulin
(1:5,000) or mouse anti-CHK1 (1:1000, Sigma-Aldrich)
antibodies. After incubation with the corresponding sec-
ondary antibodies donkey anti-rabbit (1:2000; Amersham
Biosciences, Freiburg, Germany) and goat anti-mouse
(1:10,000; Dako, Hamburg, Germany), the immunoreac-
tive proteins were visualized using a technique based on a
chemiluminescent reaction. The gel pictures were
obtained with a Bio-Rad imager (Bio-Rad laboratories,
Munich, Germany). Western blot experiments were run
in triplicate.
Results
Phenotype of patients with MCPH3
The first son (Patient 1) was born prematurely to Italian
parents who were third cousins (Figure 1A), at gesta-
tional week 35, with a birth weight of 2570 g (exact birth
parameters not available). At the age of 3 months, he
weighed 4530 g (370 g < 3rd centile), was 53 cm long
(3,9 cm <3rd centile, -4.1 SD), and had an occipital-
frontal head circumference (OFC) of 33,5 cm (4,8 cm <
3rd centile, -5.9 SD). Further progression of the OFC is
shown in Figure 1B. A closed fontanel, a simian crease,
an abdominal hernia and slightly increased muscle re-
flexes, but no pyramidal signs were observed. Skeletal
scintigraphy ruled out craniosynostosis (premature clos-
ure of the fontanels) as a cause of microcephaly. The re-
sults of routine blood tests including a full blood count,
electrolytes, liver, kidney and thyroid parameters, CK
and tests for TORCH and metabolic diseases were nor-
mal. Clearly defined areas of hyperpigmentation were
apparent on the medial side of the right leg, left ankle
and left pectoral. Chromosome analysis revealed a nor-
mal male karyotype. The results of an ophthalmological
investigation as well as ultrasound of the kidneys and
hip joints were normal. At age 4,5 months, audio-
acoustic emissions could not be detected, and brainstem
audiometry revealed a slightly elevated absolute thresh-
old of hearing of 35–40 dB. However at age 1 year tests
(BERA) were repeated, and his hearing was found to be
normal. On cranial MRI, microencephaly, simplified
gyral pattern, particularly frontally, and agenesis of the
corpus callosum were apparent (Figure 1C, 5–8). On
EEG, the oscillations were slower than expected for age,
but epileptic discharges were absent. His initial short
stature appeared to become less prominent with age, so
that at age 9 years his height was average. At age 8 years
the following tests were performed, all with normal re-
sults: full blood count, differential blood analysis, glu-
cose, creatinine, CK, LDH, GOT, GPT, TSH, T4. An IQ
test revealed intellectual disability (IQ 50–69) with slight
developmental delay in speech and motor functions,
and a short concentration span. According to the
Munich Functional Development test (MFE II) at age
5 years his speech and understanding were at an age of
27–36 months and expressive speech was at an age of
25–34 months. Moreover the boy suffered from a tic
disorder manifesting as repetitive blinking, nodding or
smacking of the lips. He had behavioral problems, with
hyperactivity, bouts of rage and aggression, which were
severe enough to necessitate short-term admission to a
childrens’ psychiatric hospital at age 11 years. He was
socially inept, easily upset and irascible. However, the
behavioral problems responded well to treatment with
risperidone.
The second son (Patient 2) was born in the 40th week
of gestation with a birth weight of 3130 g (25th-50th cen-
tile), 49 cm long (25th-50th centile) and OFC of 30 cm
(2,1 cm <3rd centile, -3.5 SD). Apgar scores were 9/10/
10. Full blood count, differential blood analysis, TORCH
and newborn metabolic screening, CK, electrolytes, liver
and kidney parameters were all normal. Shortly after
birth, intermittent breathing pauses were observed, but
never again observed thereafter. He had dysmorphic fea-
tures including a sloping forehead, low set ears, a rela-
tively high-arched palate and simian creases. Similar to
his brother, he had relatively large, map-like areas of
hyperpigmentation with well-defined borders: four on
his inner right leg, five around the ankle, and one on his
left pectoral. The further development of the OFC is
shown in Figure 1B. Chromosome analysis and tests for lac-
tate, LDH, GOT, GPT and AP at age six months were nor-
mal. All further investigations including electrocardiogram
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(ECG), ultrasound of the cranium, hips, kidneys, adrenals,
bladder as well as an ophthalmological examination
yielded normal results. Cranial MRI at the age of five
months showed microencephaly, simplified gyral pattern
particularly of the frontal lobes and corpus callosum
hypogenesis (Figure 2C, 9–12). Moreover, an increased
space in the posterior fossa, consistent with a mega-
cisterna magna most probably secondary to mild cerebel-
lar hypoplasia, could be visualized (Figure 2C, 10). At age
11 months, the patient had developed normally with re-
spect to motor skills; however, two years later mild motor
and intellectual developmental delay was noted with an
index value of 56 for cognitive development on the Bayley
Scales of Infant Development. Although he had relatively
good speech development, especially considering that he
was brought up to be bilingual, he had similar behavioral
problems to his brother, with temper tantrums, problems
with motivation and concentration and was not able to at-
tend a regular nursery school. Neither of the patients had
seizures by ages 11 years (Patient 1) and 6 years (Patient
2). The patients’ parents did not consent to the publica-
tion of photos of the patients. The clinical findings in both
patients as well as those of previously published patients
are summarized in Table 1.
Figure 1 Clinical features of MCPH3 patients with novel CDK5RAP2 gene mutation. (A) Pedigree of the Italian family: the parents were third
degree cousins. (B) Development of the OFC of both patients, from age 2 months to 5 years in patient 1 (triangles) and birth to 3 years
10 months in patient 2 (dots) (centiles refer to WHO Child Growth Standards) [10,11]. The OFC of patient 2 was below −3.5 SD at birth and
further decreased to about −6.4 SD by the age of 3 years and 10 months. (C) T1/2-weighted magnetic resonance images (MRI) of patient 1 at
age 2,5 months (5–8) and patient 2 at 3 months (9–12) compared to those of a healthy 3-year old boy. The reduced size of the brain with extra-
axial spaces (5, 7, 9–11), sloping forehead (6, 7, 11), simplified gyral pattern frontally with shallow, wide sulci (5, 7, 9) and corpus callosum agenesis
(6) and hypogenesis (10) are apparent.
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A novel CDK5RAP2 mutation in a family with MCPH
Haplotype analysis using microsatellite markers revealed
that both affected sons in the family were homozygous
for a haplotype surrounding the MCPH3 locus, shared
by the heterozygous parents, who are third degree cous-
ins. Possible linkage consistent with compound hete-
rozygosity in both sons was also suggested for the
MCPH4, MCPH7 and PNKP loci; however, sequencing
of the STIL and PNKP genes did not reveal mutations.
Sequencing of CDK5RAP2 showed that both affected
sons were homozygous for the mutation c.4441C > T,
which results in the nonsense mutation p.Arg1481*; both
parents were heterozygous for the mutation (Figure 2).
The resulting CDK5RAP2 protein is predicted to result
in a truncation that affects the second SMC, the
pericentrin, and the Golgi binding sites (Figure 2).
Cellular phenotype of patients with CDK5RAP2 gene
mutation
We investigated the pathogenicity of the identified mis-
sense mutation in immortalized lymphocytes (LCLs) from
the two patients with MCPH3 and from controls. In con-
trol LCLs, CDK5RAP2 localized to the centrosomes
during each stage of the cell cycle (Figure 3). Consistent
with studies in murine cells [12], centrosomal CDK5RAP2
levels were relatively low during interphase, increased in
the subsequent prophase and remained high throughout
mitosis until telophase, when signals dropped to inter-
phase levels. CDK5RAP2 further accumulates at the Golgi
apparatus [13], and we detected a partial colocalization
with the cis-Golgi matrix protein GM130 in LCLs during
inter- and prophase. In prometaphase, the Golgi apparatus
begins to fragment and loses its pericentriolar location
close to CDK5RAP2 (Figure 4). In metaphase and ana-
phase the fragments were still somewhat dispersed in
the cytoplasm but some could already be detected in
the proximity of the CDK5RAP2-positive centrosomes.
During telophase, cytokinesis separates the two daughter
cells, and reassembly of the Golgi apparatus occurs in the
centrosomal region of each daughter cell. In CDK5RAP2
mutant LCLs, CDK5RAP2 levels were below detection
levels when assessed through immunocytology and
Figure 2 Novel CDK5RAP2 gene mutation in patients with MCPH3. (A) Schematic representation of the domain structure of CDK5RAP2
showing the positions and the effects of CDK5RAP2 mutations that cause MCPH3. Nonsense mutation c.4441C > T is shown as a solid arrow and
previously described CDK5RAP2 mutations as dotted arrows. (B) Predicted protein products that result from the CDK5RAP2 gene mutations. The
star indicates the binding site of the anti-CDK5RAP2 antibody utilized in this study. (C) Electropherogram shows mutation c.4441C > T in patient 1
and the normal sequence in a control.
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Table 1 Summary of the clinical features in the patients described in this report (P1 = patient 1, P2 = patient 2), together with those from previous publications
(− = not reported)
CDK5RAP2 mutation Exon 4: 246 T > A Exon 4: 246 T > A Exon 8: 700G > T Intron 26: IVS26-15A > G Exon 30: 4441C > T
No. (sex) patients,
ethnicity
4 (3f, 1 m) Northern Pakistani 4 (2f, 2 m) Northern Pakistani 1 (f) Somalian 2 (f) Northern Pakistani 2 (m) Italian
Microcephaly at birth yes yes yes (−3.7 SDS) yes yes (−3.5 SDS)
Microcephaly later −6 to −8 SDS −4 to −7 SDS −8.9 SDS −5 to −7 SDS −3.5 to −5.9 SDS
Height/weight at birth - 1 patient with low birth weight
(1.9 kg at term)
low birth weight at term
(2.4 kg, -2.4 SDS) and length
(−3.7 SDS)
- P1: height −4.1 SD at 3 m; P2:
Normal (25th-50th centile)
Height/weight later - - - - P1: normal at age 9y; P2: 3rd
centile at age 2y
Intellectual disability mild-moderate mild-moderate (IQ51-65) - moderate mild-moderate (IQ50-69)
Speech disorder - - - - yes
Sloping forehead yes yes yes yes yes
Other malformations - - - - Simian crease, large map-like
hyperpigmentation
Milestones - - slightly delayed - slightly delayed
Muscular Hypotonia - - yes - high-arched palate in patient 2
Muscle reflexes - - - - increased in patient 1 (no
pyramidal signs)
Joint laxity - - yes - no
Decreased muscle bulk - - yes - no
Behavioral problems - - no - yes, severe irritability and
aggression
Hearing one patient (f) with profound
congenital sensorineural deafness
- postnatal onset moderate-
severe sensorineural deafness
- no
Malignancy acute lymphoblastic leukemiain
one female patient
- - - no
Seizures one female patient - - - no
cMRI - - microcephaly, no structural
abnormality
not reported microcephaly, simplified gyral
pattern frontally, corpus callosum
agenesis/hypogenesis (P1 and P2)
Other gastrostomy feeding needed abdominal hernia (P1)



















Figure 3 (See legend on next page.)
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western blots using two antibodies that bind to different
positions at the C-termini of full-length CDK5RAP2
(Figure 3). Since the Golgi domain described previously at
the C-terminus [13] is predicted to be lost in our patients,
we further analyzed the Golgi integrity through immuno-
staining with GM130. GM130 immuno-signal clusters
were apparent in interphase cells from patients. However,
Golgi fragmentation appeared to occur earlier during mi-
tosis and had disappeared by prophase (Figure 4).
Because CDK5RAP2 impacts on human brain size and
has been associated with progenitor proliferation, we
next sought to examine the integrity of the centrosome
and the establishment of the mitotic spindle apparatus
in patients and controls. CDK5RAP2 colocalized with
the centrosomal protein γ-tubulin throughout the cell
cycle in control LCLs (Figure 3). In patient cells where
CDK5RAP2 was below the detection level, we did not
observe a complete loss of γ-tubulin from the centro-
some nor a massive reduction of total γ-tubulin via
western blot, but rather a more dispersed γ-tubulin
staining around the centrosome (Figure 3). Pericentrin
localization was normal in patient cells when compared
to control cells (Figure 5). In addition, spindle defects
with an increase of abnormal spindles with broad and
unfocused poles of microtubuli (41% and 55% versus 9%
of 100 counted metaphase LCLs of patient 1 and 2 ver-
sus control; One-way ANOVA, p < 0.001) were detected
in CDK5RAP2 mutant LCLs (Figure 6). There was a
trend in patients towards an increase in multipolar spin-
dles (4% and 11% versus 3.5% of 100 counted metaphase
LCLs of patient 1 (not significant) and 2 (p < 0.05) ver-
sus control; One-way ANOVA) and a decrease of spin-
dle pole distance (5.4 μm and 4.8 μm versus 5.8 μm of
100 counted metaphase LCLs of patient 1 (not signifi-
cant) and 2 (p < 0.05) versus control; One-way ANOVA)
in CDK5RAP2 mutant LCLs (Figure 6). Also several
LCLs from patients showed lagging chromosomes, this
was significantly increased in one of the patients (pa-
tient 2) and only showed a tendency to be increased in
the other patient. CHK1 protein has been shown to be
downregulated in Cdk5rap2 mutant cells [14]. Although
slightly reduced in both patient cell lines as compared
to the control, the difference in the concentration of
CHK1 protein was not significant (Figure 7).
Discussion
In the present study, we have identified the novel non-
sense mutation c.4441C > T (R1481*) in the CDK5RAP2
gene in a homozygous constellation in two boys of Ital-
ian descent with primary microcephaly (Figures 1 and
2). We thereby, for the first time, provide detailed clin-
ical and radiological information on MCPH3 patients of
European descent. The siblings suffer from congenital
microcephaly, intellectual disability, speech deficit, a tic
disorder and severe behavioral problems. Further tests
did not reveal any significant hearing impairment or
epilepsy as a cause for the speech deficit. Therefore, al-
though sensorineural hearing loss has been reported in
two patients with mutations in CDK5RAP2 [5,15], this is
not a consistent finding in MCPH3. Both patients had
microcephaly, simplified gyral pattern of the cerebral
cortex, with shallow sulci anteriorly and deep sulci
parietally and posteriorly, and corpus callosum hypo-
gensis on cMRI. There was no particular evidence of
reduced white matter volume in the patients, despite the
fact that CDK5RAP2 is expressed in glial cells of the
developing rodent brain. Why the white matter is not
more severely affected in MCPH remains unclear. Future
studies will need to address the question as to what ex-
tent white matter disease also contributes to brain size
reduction in MCPH patients. It is unclear whether these
clinical and radiological features are also present in the
previously reported three pedigrees of Pakistani descent
with MCPH due to homozygous CDK5RAP2 mutations.
In addition to the brain, we recently reported that
CDK5RAP2 is widely expressed in various organs of new-
born mice and human fetuses with high CDK5RAP2
mRNA and protein levels in the thymus and the kidney [7].
Moreover, it has been reported that in the MCPH3 murine
model‚ “Hertwig’s anemia” mice display defects in multiple
organs including the thymus and also have a hematopoietic
phenotype (hypoproliferative anemia, leucopenia, predis-
position to hematopoietic tumors) [16]. In other MCPH
subtypes, individual patients have been reported with short
stature (especially in MCPH1 and MCPH5 [17-19]), early
puberty, renal agenesis and polycystic kidneys [17]. As this
point warrants further investigation in patients, we investi-
gated the clinical phenotype of our patients in detail
with respect to multi-organ involvement. Short stature was
(See figure on previous page.)
Figure 3 CDK5RAP2 in immortalized lymphocytes and dispersion of centrosomal protein γ-tubulin in CDK5RAP2 mutant patients cells.
CDK5RAP2 protein levels were below detection level in immortalized lymphocytes from both patients with the c.4441C > T CDK5RAP2 mutation
when assessed by (A) Western blot and (B) immunocytology. Subcellular localization of CDK5RAP2 and γ-tubulin throughout the cell cycle in
immortalized lymphocytes of (C) controls and (D) MCPH3 patient 2. In controls, centrosomal CDK5RAP2 levels were weak during interphase,
increased in the subsequent prophase and remained high throughout mitosis until telophase, when signals dropped to interphase levels. In the
patient cells the alignment of the chromosomes at the spindle poles was less precise than in the control cells. Cells were stained with CDK5RAP2
(red), γ-tubulin (green) as a centrosomal marker, and DNA is stained with DAPI (blue). Scale bars 10 μm. Western blot results reveal that total γ-
tubulin protein levels are similar in patients and controls (Additional file 1: Figure S1).
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Figure 4 Golgi apparatus marker GM130 in CDK5RAP2 mutant patients cells. Subcellular localization of CDK5RAP2 and GM130 throughout
the cell cycle in immortalized lymphocytes of (A) control and (B) MCPH3 patient 2. Golgi fragmentation appeared to occur earlier during mitosis,
already showing a dispersed signal during prophase in patient cells.
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Figure 5 Pericentrin in CDK5RAP2 mutant patient and control cells. No difference was detected regarding the subcellular localization of
pericentrin throughout the cell cycle in immortalized lymphocytes of (A) control and (B) MCPH3 patients (here patient 2), however the staining in
patients was weaker and the signal more diffuse.
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Figure 6 (See legend on next page.)
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detected in both patients up to an age of two years, but
thereafter normalized in patient 1 for whom detailed data
were available. This normalization of height after infancy
(in contrast to the pattern of head growth) is a disease fea-
ture that has been reported similarly in patients with ASPM
gene mutations [18]. There was no evidence of further
organ involvement or malignancy, specifically no anemia or
leucopenia and no kidney or thymus abnormality.
The three homozygous mutations in the CDK5RAP2
gene reported so far, 246T > A in exon 4, 700G > T in
exon 8 and 4005-15A >G in intron 26, have been pro-
posed, but not shown, to lead to truncated proteins of 82
(Y82*), 234 (E234*) and 1334 (R1334Sfs*5) amino acids,
respectively, and a loss of CDK5RAP2 function (full length
protein 1893 amino acids; Figure 1). While the first
and second mutant protein should lack most of the
CDK5RAP2 transcript except for the N-terminus inclu-
ding a part of the γTuRC-binding domain or the N-
terminus including the complete γTuRC-binding domain
and a part of the SMC-domain, respectively, the third pro-
tein should lack the C-terminus of CDK5RAP2, especially
the c-terminal SMC domain as well as the pericentrin and
the Golgi binding sites. The homozygous nonsense muta-
tion reported here, 4441C > T in exon 30, is predicted to
lead to a truncated protein of 1481 amino acids (R1481*).
The resulting CDK5RAP2 protein in our patients should
lack parts of the second SMC domain as well as the
pericentrin and the Golgi binding sites (Figure 1). No
studies on patient specimen exist that shed light on the
effect of the reported CDK5RAP2 gene mutations. We re-
cently reported a high CDK5RAP2 expression in prolife-
rating progenitors of the germinal matrix and early (not
mature) neurons as well as glial cells in the neocortex of
murine embryos and human fetuses [7]. This is in con-
cordance with results of neuroimaging studies in MCPH
patients due to non-CDK5RAP2 mutations demonstrating
a reduced brain volume that affects especially the neocor-
tex [17,18]. Based on results from in vivo and in vitro
studies, the human MCPH phenotype is considered to be
the result of a premature shift from symmetric to asym-
metric neural progenitor-cell divisions (with a subsequent
depletion of the progenitor pool) as well as of a reduction
in cell survival [6,8].
To study the effect of the reported CDK5RAP2 gene
mutation on cell proliferation in our patients, we studied
EBV-transformed lymphocytes (LCLs) from both of our
patients and from controls. Here, CDK5RAP2 localized to
the centrosomes during each stage of the cell cycle in con-
trols but was absent from patient cells, when assessed via
immunocytology and western blots (Figure 3). The latter
finding of CDK5RAP2 levels below detection levels in cells
of our patients indicates that very little or no protein is
present secondary to nonsense-mediated decay of the mu-
tated transcript. In contrast to Cdk5rap2 shRNAi studies
performed on mouse tissues [20], we detected a failure of
the centrosomal protein γ-tubulin to localize properly at
the centrosome, while total γ-tubulin protein levels were
normal in patient cells (Figure 3, Additional file 1: Figure
S1). Pericentrin, which interacts with CDK5RAP2 through
defined protein domains [21], was not altered in its
localization in patient LCLs (Figure 5). This result is in
line with those of Buchman et al. 2010 [21] who con-
cluded from their studies in murine tissues that the
centrosomal recruitment of pericentrin is not dependent
upon Cdk5rap2, while the converse is true. Despite the
predicted loss of the C-terminal Golgi domain in mutant
Figure 7 CHK1 in CDK5RAP2 mutant patient and control LCLs. (A, B) Total CHK1 protein levels detected via Western blots in immortalized
lymphocytes of controls and MCPH3 patients did not differ significantly.
(See figure on previous page.)
Figure 6 Spindle defects in CDK5RAP2 mutant patients cells. Subcellular localization of CDK5RAP2 and α-tubulin throughout the cell cycle in
immortalized lymphocytes of (A) control and (B) MCPH3 patient 2. In controls, CDK5RAP2 is weak and centrosomal during interphase and shows
abnormal spindle formation. In patients, spindle pole formation did not appear to be as precise as in the control cells, with the chromosomes not
as uniformly positioned at the spindle poles. Cells were stained with CDK5RAP2 (red), α-tubulin (green) as a centrosomal marker, and DNA is
stained with DAPI (blue). Scale bars 10 μm. (C) Quantification results of abnormal spindles (unfocused α-tubulin staining at spindle poles),
multipolar spindles and spindle pole distance.
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CDK5RAP2, the Golgi apparatus could be visualized
normally using immunostaining with GM130. However,
Golgi fragmentation appeared to occur earlier during mi-
tosis and had disappeared by prophase (Figure 4). Further,
we observed an unfocused and disorganized mitotic
microtubule assembly, a decrease in spindle pole distance
and a trend towards more multipolar spindle poles as well
as chromosome misalignment in patient cells (Figure 6).
These results, although generated in lymphocytes and not
neural progenitors, suggest that spindle defects and a dis-
ruption of centrosome integrity could play a role in the de-
velopment of microcephaly in MCPH. On the other hand,
they also underline the fact that, at least in the cells stud-
ied, despite a lack of normal CDK5RAP2, a centrosomal
structure can still be formed, microtubuli can still be
nucleated to the centrosomes and cells can still divide.
Since microcephalin and pericentrin regulate mitotic
entry via centrosome-associated Chk1 [22] and Chk1-
downregulation has been demonstrated in mutant Cdk5rap2
cells [14], we analyzed CHK1 levels in CDK5RAP2 mutant
and control cells. Although slightly reduced in both patients,
there was not a significant decrease in total CHK1 levels in
patients cells (Figure 7).
Brain size at birth is largely determined by the relative
rates of proliferation and cell death. By highlighting the
clinical, radiological and cellular phenotype of MCPH3
patients, we offer a further glimpse into how a disrup-
tion of the CDK5RAP2 gene may impact on the develop-
ment in humans. Further analysis of patient samples
provides a means to investigate processes that cause
MCPH and to verify mechanisms described in other
model systems and in settings where animal models are
neither sufficient nor satisfactory.
Additional file
Additional file 1: Figure S1. Gamma tubulin in CDK5RAP2 mutant
patient and control LCLs. (A, B) Total gamma tubulin protein levels
detected via Western blots in immortalized lymphocytes of controls and
MCPH3 patients did not differ significantly.
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